malvidin has been researched along with Insulin Resistance in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, X; Li, X; Zhang, C; Zhu, H; Zou, W | 1 |
| Mackert, JD; McIntosh, MK | 1 |
2 other study(ies) available for malvidin and Insulin Resistance
| Article | Year |
|---|---|
Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats.
Topics: Animals; Anthocyanins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Progression; Drug Therapy, Combination; Glucose; Hypoglycemic Agents; Inflammation; Insulin Resistance; Lipid Metabolism; Male; Metformin; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley | 2021 |
Combination of the anthocyanidins malvidin and peonidin attenuates lipopolysaccharide-mediated inflammatory gene expression in primary human adipocytes.
Topics: Adipocytes; Adipose Tissue; Anthocyanins; Drug Synergism; Gene Expression; Humans; Inflammation; Inflammation Mediators; Insulin Resistance; Interleukins; Lipolysis; Lipopolysaccharides; Phytotherapy; Plant Extracts; Polyphenols; RNA, Messenger; Vitis | 2016 |